Annia Martial

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background The treatment algorithm for metastatic non-small cell lung cancers (NSCLCs) has been evolving rapidly due to the development of new therapeutic agents. Although guidelines are provided by National Comprehensive Cancer Network (NCCN) for treatment options according to biomarker testing results, sequentially applying the three main modalities(More)
  • 1